Approval · Notice of Compliance 23382 · 2020
CELLCEPT I.V.: Notice of Compliance 23382
Issued March 24, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23382
- Date
- March 24, 2020
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of production line ATM4, and increase in batch size
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELLCEPT I.V. | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL HYDROCHLORIDE 500 MG per VIAL